November 23, 2021
This Weekly's Hot Topics
  • Clinical Trial Database, LIVE on the MOASC website MOASC News
  • MOASC’s Lung Cancer Webinar Series, to begin in January 2022 MOASC Programs
  • Cancer Research Through a Health Equity Lens California News
MOASC acknowledges and thanks Jazz Pharmaceuticals as an annual Platinum sponsor. Please welcome and THANK them for supporting your organization, when they call or e-mail you. Jazz Pharmaceuticals is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. Jazz is focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, Jazz is working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.
MOASC has been able to create a Clinical Trial Database, LIVE on the MOASC website at, through such generous grants and affording new opportunities for MOASC members. The MOASC Clinical Trial Committee is actively looking for ways to assist its members with Clinical Trial promotion and recruitment, through the creation of a database for both physicians and patients. If you are interested in adding your active clinical trials to the database, please contact Nichole East at
Clinical Trial Committee consists of Edward McClay, MD, California Cancer Associates for Research & Excellence (CCARE); Kevin Chang, MD, Ventura Hematology Oncology Medical Group; Ashkan Lashkari, MD, Wellness Oncology; Joshua Mansour, MD, City of Hope and Robert Moss, MD.

MOASC supports Debra A. Patt, M.D. for the ASCO Board. Please take time to vote, and encourage your partners to vote, in the ASCO election. The voting period closes on Tuesday, December 7, 2021, at 12:00pm PST, all ballots must be received by this time.
MOASC Programs - Save the Dates - All Times are Pacific
Announcement from President, Ashkan Lashkari, MD.
We are proud to announce our inaugural Lung Cancer Webinar Series, which is slated to begin in January of 2022. The goal of this webinar series is to engage our members in lively discussion and review the latest updates in the management of lung cancer. We will hold each discussion once a month virtually and set aside one hour to review a particular topic within this ever more differentiated area of oncology. Our series will be moderated by Dr. Hatim Hussain, Assistant Professor of Medicine at USCD, and he will be joined by one to two expert discussants to provide discussion for our members to both listen to and participate in. Our first webinar scheduled for January 26, 2022, will focus on the management of metastatic EGFR mutated non-small cell lung cancer.  
Below you will see the dates of each webinar in our 2022 series. We hope to see you there. 
1. January 26 Treatment of EGFR NSCLC
2. February 23 Treatment of KRAS mutated NSCLC
3. March 30 Treatment of ALK NSCLC
4. April 27 Treatment of other targetable mutations (ROS/RET/EGFR exon 20/ NTRK/HER2)      Sponsored by: Johnson & Johnson
5. May 25 Molecular diagnostics in NSCLC-liquid and tissue NGS
6. June 29 IO therapy in the metastatic setting
7. July 27 Adjuvant therapy (EGFR/PD-L1 etc.)
8. August 31 Treatment of Unresectable stage 3 disease
9. September 28 Neo-adjuvant treatment of Resectable lung cancer
10. October 26 Lung cancer screening
For more information, please contact
December 1, 5:30pm- MOASC Clinical Webinar “Medicare in 2022,"Presented by: Arthur Lurvey, M.D., FACP, FACE, Medicare Contractor Medical Director. Topics include: 2022 Final Fee Schedule and Regulation Changes; Telehealth in 2022; Restarting of Target Probe- and Education and Review Topics; Brief Restating of Appeals and Document Recommendations and Off-Label Use of Medications.
 The University of California San Diego cordially invites you to their Great Debates in Advanced Cutaneous Squamous Cell Carcinoma (CSCC), December 4, 8:30am. This virtual meeting will provide a multidisciplinary management approach for patients with advanced CSCC. Topics will focus on updates in risk assessment, pathology, radiation therapy medical & surgical management, featuring case presentations alongside plenary sessions followed by a question and answer opportunity. Target audiences include: dermatologists; medical, radiation and surgical oncologists; otolaryngologists; plastic surgeons; pathologists, and physicians and allied health professionals caring for patients with cutaneous squamous cell carcinoma.
Career News

City of Hope Medical Group Seeks Medical Oncologists to Join our Main Campus in Duarte and Our Expanding Network:
Duarte (main campus) | Women’s Health (Breast) Medical Oncology 60-80% clinical effort
Antelope Valley | General Medical Oncology 95% clinical effort
Corona | General Medical Oncology 95% clinical effort
Glendale | General Medical Oncology 95% clinical effort
West Covina/Glendora | General Medical Oncology 95% clinical effort
Simi Valley | General Medical Oncology 95% clinical effort
Interested candidates must submit an official application via the City of Hope Physician Careers Internet site: Physician Careers. Additionally, applicants can forward a curriculum vitae and letter of interest to
Thank you!
California News
Last Thursday, 11/18, the American Cancer Society Cancer Action Network presented a virtual event Cancer Research Through a Health Equity Lens. The content of the program exceeded expectations and the questions from all attendees raised the quality of the discussions, which will help shape ACS CAN advocacy efforts to address health equity in cancer research so that all individuals have a fair and just opportunity to prevent, find, treat, and survive cancer. 
MOASC was among 13 other sponsors of this program to further ASC CAN mission!
Medicare News
Noridian News
MLN Connects - November 18, 2021
CMS has made available the latest edition of the MLN Connects. 
MolDX: myPath® Melanoma Assay LCD - R4
This Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV). 
Annual Participation Program
CMS Internet Only Manual (IOM), Publication 100-04, Medicare Claims Processing Manual, Chapter 1, Section 30.3.12 outlines an annual open enrollment process, to provide eligible practitioners and suppliers with the opportunity to enroll in or terminate enrollment in the participation program. 
Incorrect Coinsurance Percentage Applied for Drugs and Biologicals Alert. The MCS system is calculating the copayment amount for drugs and biologicals incorrectly. 
2022 Medicare Physician Fee Schedule Now Available 
The Doctors and Clinicians Preview Period is open until December 14 at 5 pm PT. Preview your 2020 Quality Payment Program (QPP) performance information before it appears on Medicare Care Compare and in the Provider Data Catalog. Access the secured preview through the QPP website. Medicare Shared Savings Program (Shared Savings Program) Accountable Care Organizations (ACOs) and Next Generation Model ACOs can preview their performance information in their 2020 Merit-based Incentive Payment System Performance Feedback Reports. Shared Savings Program ACOs can also review quality performance information on their previously-provided 2020 Quality Performance Reports. 
 Lung Cancer Awareness: Help Your Patients Reduce Their Risk. Medicare covers lung cancer preventive services and screening. Talk to your patients about how they can lower their lung cancer risk during Lung Cancer Awareness Month and the Great American Smokeout®.
Your patients pay nothing for these services, if you accept assignment:
Noridian Programs
November 30, 2021 - Modifier 59, National Correct Coding Initiative (NCCI) and Medically Unlikely Edit (MUE).This event includes: National Correct Coding Initiatives (NCCI), Procedure to Procedure (PTP) CCI Edits, Modifier 59, Medically Unlikely Edits (MUEs), Correct Coding Initiative (CCI) Examples, Resources.
December 1, 2021 - Noridian Medicare Portal (NMP) Eligibility Webinar. This event includes: Noridian Medicare Portal, Hours of Availability, Eligibility, MBI Look Up
December 3, 2021 - Medicare Secondary Payer (MSP) Part B Billing Webinar.
This event includes: Part B MSP Billing, Payments and Calculations, Forms and Noridian Medicare Portal (NMP), Scenarios and Avoiding Delays, and Resources.
December 8, 2021 - Medicare 101 - New Providers/New Billers: Beneficiary Forms Webinar. This event includes: Important Message from Medicare, Advanced Beneficiary Notice of Noncoverage, Medicare Outpatient Observation Notice, and Hospital Issued Notice of Noncoverage.
CMS News
CMS gave drugmakers six more months to comply with the Trump-era regulation requiring them to calculate the "best price" for drugs under Medicaid's drug rebate program using discounts they offer patients. The new final rule will officially delay best prices reporting from Jan. 1, 2022, to July 1, 2022.
December 1 & 2 – HCPCS Public Meeting. The purpose of the Public Meetings is to provide a forum for the general public to present information regarding specific Healthcare Common Procedural Coding System (HCPCS) coding requests for new products, supplies, and services. The meeting also provides an opportunity to obtain industry and public reaction to the preliminary coding recommendations of the CMS HCPCS Workgroup, as well as CMS' preliminary recommendations regarding payment methodology. Coding decisions related to the Medicare and Medicaid programs internal operating procedures are reviewed internally, and are not included in this forum.
National News
Health insurers, employers and other group health plan sponsors must report prescription drug and health coverage costs for consumers under a federal regulation published last week. The interim finale rule is the fourth regulation to date implementing the No Surprises Act. The Health and Human Services Department, Labor Department, Treasury Department and Office of Personnel Management promulgated the regulation.
Telehealth may have widened care disparities for some cancer patients, as patients with high socioeconomic status accessed telehealth more frequently than those with low socioeconomic status.
The U.S. Occupational Safety and Health Administration has suspended enforcement of its requirement that large employers nationwide ensure their workers are either vaccinated against COVID-19 or tested weekly for the virus by Jan. 4 in light of a court stay, throwing President Biden’s controversial mandate into doubt. The decision followed a stay the 5th U.S. Circuit Court of Appeals in New Orleans granted Friday in a lawsuit seeking to block the mandate filed on behalf of various companies, religious groups, private citizens and the states of Texas, Louisiana, Mississippi, South Carolina and Utah.
Affiliate Association News

Please take time to vote in the ASCO election. Please encourage your partners to vote in the ASCO election. The voting period closes on Tuesday, December 7, 2021, at 12:00pm PST, all ballots must be received by this time.
ASH News
Start preparing your application for the ASH Medical Educators Institute. The ASH Medical Educators Institute (MEI) is a year-long program, which includes a webinar series and in-person workshop, that develops future leaders in hematology education by providing a "boot camp" in teaching techniques, medical education scholarship, and career development. The application will be available on February 1, 2022. Review the application process and eligibility requirements
COA News
If you missed or wish to re-watch, last Wednesday’s Congressional PBM forum in which COA Executive Director, Ted Okon testified, the link is below. When you click on it, it will say Livestream Begins Soon, but if you click on play and slide the bar down to the 21:45 minute mark, the forum begins.
Industry News
Janssen Biotech cordially invites you to their 7th Fall IDEA Healthcare Summit, December 2, 2021. Attendees will explore what providers, caregivers, advocates, employers, payers, and pharmaceutical companies can do to elevate the patient voice. Panelists will discuss the elements of effective self-advocacy in health care and how we can cultivate those practices. Our goal is a health care system that is responsive to needs and centered around access, affordability, and innovation. Panelists will explore barriers to health self-advocacy, with a focus on underserved communities, and what can be done to overcome these barriers and help people be heard and better served. 
Just 1 week away from the 2021 Premier Alternate Site Programs Virtual National Meeting taking place virtually on Thursday, December 2 and Friday, December 3. With keynote speaker headliner Captain Chesley “Sully” Sullenberger, “Miracle on the Hudson” Pilot and Safety Expert, featured session speakers will cover trending topics in four unique tracks: Clinical and Compliance Outcomes, Legislative & Regulatory Updates, Business Management and Operations, and Supply Chain Strategies. There is an updated agenda and Business Track speakers below, that reflect the informative and engaging virtual program. Please register today to secure your spot!
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.